Psychometric benefits of adding four bolt-ons (skin irritation, self-confidence, social relationships and sleep) to EQ-5D-5L compared to PROMIS-29 and Skindex-16 in patients with psoriasis and atopic dermatitis.
Sandra N Naguib, Zhuxin Mao, Dina G Saadi, Aureliano Finch, Maggie Abbassi, Samar Farid
{"title":"Psychometric benefits of adding four bolt-ons (skin irritation, self-confidence, social relationships and sleep) to EQ-5D-5L compared to PROMIS-29 and Skindex-16 in patients with psoriasis and atopic dermatitis.","authors":"Sandra N Naguib, Zhuxin Mao, Dina G Saadi, Aureliano Finch, Maggie Abbassi, Samar Farid","doi":"10.1007/s10198-026-01970-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to evaluate the impact of adding four bolt-ons (skin irritation (SI), self-confidence (SE), social relationships (SR) and sleep (SL)) on psychometric performance of EQ-5D-5L and compare it to PROMIS-29 and Skindex-16 in patients with psoriasis (Ps) and atopic dermatitis (AD).</p><p><strong>Methods: </strong>Paper-based questionnaires were completed by 125 Ps and 111 AD patients at dermatology outpatient clinics in Egypt, most had moderate-to-severe disease. Psychometric evaluation included ceiling effect, informativity, convergent validity, explanatory power for variances in EQ VAS, and the discriminatory ability across severity subgroups defined by clinical and patient reported indices. Both dimension-level scores and Level Sum Scores (LSS), standardized to a 5-25 scale, were used to assess the psychometric performance of EQ-5D-5L with bolt-ons.</p><p><strong>Results: </strong>The EQ-5D-5L showed a low ceiling effect (3.4%), which was eliminated after adding SI bolt-on and reduced to 1.3-3% with the other three bolt-ons. PROMIS-29 and Skindex-16 showed no ceiling effect. Average relative informativity was highest for PROMIS-29 (0.96), followed by EQ-5D-5L+bolt-ons (0.9) and Skindex-16 (0.85). Known-group validity analyses showed that adding bolt-ons produced the highest relative efficiency, outperforming both the core EQ-5D-5L and Skindex-16. EQ-5D-5L + SI explained 51% of EQ VAS variance in Ps, while the combination of all bolt-ons explained 39% in AD; PROMIS-29 and Skindex-16 explained 25% and 21%, respectively. Convergent validity supported predefined hypotheses, with SI and SL showing strongest correlations with clinical outcomes. However, strong correlations were observed between SR and SE with Anxiety/Depression in Ps group.</p><p><strong>Conclusion: </strong>Adding bolt-ons enhanced EQ-5D-5L performance across all psychometric properties, making it an acceptable alternative to Skindex-16 in Ps and AD. SI and SL consistently showed the greatest benefits. SE and SR showed selective benefits. Longitudinal data will be published separately.</p>","PeriodicalId":51416,"journal":{"name":"European Journal of Health Economics","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Health Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10198-026-01970-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study aimed to evaluate the impact of adding four bolt-ons (skin irritation (SI), self-confidence (SE), social relationships (SR) and sleep (SL)) on psychometric performance of EQ-5D-5L and compare it to PROMIS-29 and Skindex-16 in patients with psoriasis (Ps) and atopic dermatitis (AD).
Methods: Paper-based questionnaires were completed by 125 Ps and 111 AD patients at dermatology outpatient clinics in Egypt, most had moderate-to-severe disease. Psychometric evaluation included ceiling effect, informativity, convergent validity, explanatory power for variances in EQ VAS, and the discriminatory ability across severity subgroups defined by clinical and patient reported indices. Both dimension-level scores and Level Sum Scores (LSS), standardized to a 5-25 scale, were used to assess the psychometric performance of EQ-5D-5L with bolt-ons.
Results: The EQ-5D-5L showed a low ceiling effect (3.4%), which was eliminated after adding SI bolt-on and reduced to 1.3-3% with the other three bolt-ons. PROMIS-29 and Skindex-16 showed no ceiling effect. Average relative informativity was highest for PROMIS-29 (0.96), followed by EQ-5D-5L+bolt-ons (0.9) and Skindex-16 (0.85). Known-group validity analyses showed that adding bolt-ons produced the highest relative efficiency, outperforming both the core EQ-5D-5L and Skindex-16. EQ-5D-5L + SI explained 51% of EQ VAS variance in Ps, while the combination of all bolt-ons explained 39% in AD; PROMIS-29 and Skindex-16 explained 25% and 21%, respectively. Convergent validity supported predefined hypotheses, with SI and SL showing strongest correlations with clinical outcomes. However, strong correlations were observed between SR and SE with Anxiety/Depression in Ps group.
Conclusion: Adding bolt-ons enhanced EQ-5D-5L performance across all psychometric properties, making it an acceptable alternative to Skindex-16 in Ps and AD. SI and SL consistently showed the greatest benefits. SE and SR showed selective benefits. Longitudinal data will be published separately.
期刊介绍：
The European Journal of Health Economics is a journal of Health Economics and associated disciplines. The growing demand for health economics and the introduction of new guidelines in various European countries were the motivation to generate a highly scientific and at the same time practice oriented journal considering the requirements of various health care systems in Europe. The international scientific board of opinion leaders guarantees high-quality, peer-reviewed publications as well as articles for pragmatic approaches in the field of health economics. We intend to cover all aspects of health economics:
• Basics of health economic approaches and methods
• Pharmacoeconomics
• Health Care Systems
• Pricing and Reimbursement Systems
• Quality-of-Life-Studies The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.
Officially cited as: Eur J Health Econ
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
